These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18508316)

  • 21. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
    Wang B; Hsu SH; Majumder S; Kutay H; Huang W; Jacob ST; Ghoshal K
    Oncogene; 2010 Mar; 29(12):1787-97. PubMed ID: 20023698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sakitani K; Yamashiki N; Seki T; Saito H; Nishizawa M; Fujisawa J; Inoue K
    Cancer Res; 2000 Mar; 60(5):1394-402. PubMed ID: 10728705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Chae DK; Ban E; Yoo YS; Kim EE; Baik JH; Song EJ
    Mol Carcinog; 2017 Aug; 56(8):1992-1998. PubMed ID: 28370334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.
    He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS
    Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells.
    Chandran PA; Keller A; Weinmann L; Seida AA; Braun M; Andreev K; Fischer B; Horn E; Schwinn S; Junker M; Houben R; Dombrowski Y; Dietl J; Finotto S; Wölfl M; Meister G; Wischhusen J
    J Leukoc Biol; 2014 Oct; 96(4):633-45. PubMed ID: 25030422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells.
    Yan MD; Yao CJ; Chow JM; Chang CL; Hwang PA; Chuang SE; Whang-Peng J; Lai GM
    Mar Drugs; 2015 Sep; 13(10):6099-116. PubMed ID: 26404322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
    Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
    Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
    PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss-of-function of miR-142 by hypermethylation promotes TGF-β-mediated tumour growth and metastasis in hepatocellular carcinoma.
    Yu Q; Xiang L; Yin L; Liu X; Yang D; Zhou J
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28963738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.
    Feng XX; Luo J; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Feng ZH; Tian DA
    Cancer Sci; 2015 May; 106(5):559-66. PubMed ID: 25683165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells.
    Zhang Y; Gong W; Dai S; Huang G; Shen X; Gao M; Xu Z; Zeng Y; He F
    Mol Cancer Res; 2012 Apr; 10(4):516-22. PubMed ID: 22446874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibition of microRNA-15a suppresses hepatitis B virus-associated liver cancer cell growth through the Smad/TGF-β pathway.
    Wang Y
    Oncol Rep; 2017 Jun; 37(6):3520-3526. PubMed ID: 28498453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
    Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.